Women with a history of estrogen-sensitive cancers should consult an oncologist before use
Notice that NR must first convert to NMN on its trajectory toward NAD+
In an audience packed with senior R&D leadersincluding over 10 from Eli Lilly, alongside key figures from Novo Nordisk, AstraZeneca, Roche, Boehringer Ingelheim, and others the realization dawned that a traditional pharma giant had officially evolved into the first longevity pharma company
Glucose-Lowering Medications, Glycemia, and Cognitive Outcomes
April 30, 2026: The bulks-list pathway is now proposed to be closed permanently
GHK-Cu Clinical Evidence Context The cleanest way to think about GHK-Cu evidence is by route